Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [911]
News [3681]
Articles [22]
Editorials [1]
Conferences [135]
elearning [0]
PARP inhibitor, MK-4827, shows anti-tumour activity in first trial in humans
PARP inhibitor, MK-4827, shows anti-tumour activity in first trial in humans
Tiny Trojan horses attack brain cancer cells
Tiny Trojan horses attack brain cancer cells
Cough medication used to probe tamoxifen responders
Cough medication used to probe tamoxifen responders
New approach to targeting blood vessels in advanced cancer
New approach to targeting blood vessels in advanced cancer
Combination therapy improves survival time for patients with advanced liver cancer
Combination therapy improves survival time for patients with advanced liver cancer
Novel genetic mutation that causes the most common form of eye cancer discovered
Novel genetic mutation that causes the most common form of eye cancer discovered
Prostate cancer drug targeting Vitamin D receptors shows promise
Prostate cancer drug targeting Vitamin D receptors shows promise
What we are reading this week at the European Institute of Oncology
What we are reading this week at the European Institute of Oncology
Second line therapy for non-small cell lung cancer in clinical practice
Second line therapy for non-small cell lung cancer in clinical practice
Never-smokers fare far better than smokers after radiation therapy for head and neck cancer
Never-smokers fare far better than smokers after radiation therapy for head and neck cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation